Gratus Capital LLC Purchases Shares of 75718 AbbVie Inc. (ABBV)

Galtero Lara
Diciembre 8, 2017

With 7.65 million avg volume, 2 days are for Abbvie Incorporated (NYSE:ABBV)'s short sellers to cover ABBV's short positions. The institutional investor held 343,700 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $24.92M, down from 606,800 at the end of the previous reported quarter. Abbvie Inc now has $151.74B valuation. The stock decreased 0.85% or $0.96 during the last trading session, reaching $111.55. The total number of shares traded in the last 90-day period is 281,873. (NYSE:ABBV). Moreover, Sfmg Ltd has 0.05% invested in AbbVie Inc. It has underperformed by 6.07% the S&P500. Seven analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. Therefore 67% are positive. Robert W. Baird maintained the stock with "Buy" rating in Thursday, June 8 report. Deutsche Bank upgraded AbbVie Inc. The company presently has a consensus rating of "Buy" and a consensus price target of $96.66. As per Friday, September 15, the company rating was maintained by Piper Jaffray. William Blair initiated the stock with "Outperform" rating in Friday, February 5 report. As per Monday, November 6, the company rating was maintained by UBS. The rating was initiated by Atlantic Securities on Friday, December 18 with "Neutral". The shares were sold at an average price of $65.35, for a total transaction of $2,502,905.00. Shares for $3.21 million were sold by ALBAN CARLOS. TRUE Private Wealth Advisors now owns 4,814 shares of the company's stock worth $349,000 after purchasing an additional 27 shares during the last quarter.

The collective rating of 2.3 for AbbVie Inc.

ABBV has been the topic of several recent analyst reports. Leerink Swann also issued estimates for AbbVie's Q4 2018 earnings at $1.89 EPS. ABBV's profit will be $2.28 billion for 16.62 P/E if the $1.43 EPS becomes a reality. Bank of Nova Scotia lifted its holdings in shares of AbbVie by 297.9% in the 1st quarter. The other 11, though not evenly; between analysts who think you should buy AbbVie Inc. versus those who think you should sell it. Therefore 52% are positive. Orchids Paper Products Co had 4 analyst reports since October 15, 2015 according to SRatingsIntel. (NYSE:ABBV) rating on Monday, November 20. The firm has "Buy" rating given on Friday, July 14 by Jefferies. The rating was maintained by Mizuho on Tuesday, October 31 with "Buy". Barclays reaffirmed a "hold" rating and set a $68.00 price objective on shares of AbbVie in a report on Thursday, September 28th. The company was maintained on Wednesday, October 11 by BMO Capital Markets. As per Monday, December 7, the company rating was upgraded by Jefferies.

The investor is now holding 117,946,653 shares thanks to an increase of 2,025,980 new shares in their portfolio. Its up 0.01, from 0.99 in 2017Q1.

More news: 'One Day at a Time' Back on Netflix Jan. 26

A number of other hedge funds have also added to or reduced their stakes in ABBV. 14,490 were reported by Smithfield Trust. Finally, Palisade Asset Management LLC increased its stake in shares of AbbVie by 17.9% in the second quarter. Beacon Fincl Gp has invested 0.17% in AbbVie Inc. (NYSE:ABBV). Ahl Prns Limited Liability Partnership reported 77,053 shares stake. Trust Communications Of Oklahoma holds 0% of its portfolio in AbbVie Inc. (NYSE:ABBV) or 110,605 shares. Investors will get a clear idea on how much they can earn per share on each of the outstanding shares of common stock. Cowen & Co maintained AbbVie Inc. (NYSE:ABBV). Clinton Gru Inc has invested 0.41% in AbbVie Inc. (NYSE:ABBV). Hanson And Doremus Investment owns 5,609 shares. Mayo Advisers Ltd Liability Corp accumulated 9,508 shares or 0.28% of the stock. AbbVie Inc. The firm has a market capitalization of $152,315.39, a price-to-earnings ratio of 17.97, a price-to-earnings-growth ratio of 1.35 and a beta of 1.52. Legal & General Group Plc now owns 8,049,351 shares of the company's stock worth $583,658,000 after acquiring an additional 131,159 shares during the period. Investec Asset Management LTD increased its stake in shares of AbbVie by 3.6% in the first quarter.

Reports indicate current assets will be sufficient to meet the AbbVie Inc. obligations as and when they are due, however Quick ratio of $1.3 shows that there is surplus cash on hand to cover liabilities and keep going. Catawba Cap Management Va accumulated 41,036 shares or 0.68% of the stock. Bridges Investment Mngmt owns 47,175 shares for 0.46% of their portfolio. Formidable Asset Management LLC now owns 3,926 shares of the company's stock worth $285,000 after purchasing an additional 10 shares in the last quarter. Spdr Dow Jones Indl Avrg Etf U (DIA) was raised too. Skandinaviska Enskilda Banken AB publ now owns 1,202,483 shares of the company's stock worth $78,354,000 after acquiring an additional 357,353 shares during the last quarter. Cable Hill Partners LLC now owns 2,711 shares of the company's stock worth $177,000 after buying an additional 186 shares in the last quarter. Orchids Paper Products Company (NYSEMKT:TIS) has declined 56.11% since December 6, 2016 and is downtrending. It has underperformed by 16.70% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Otros informes por

Discuta este artículo

SIGUE NUESTRO PERIÓDICO